World Hepatitis Day (WHD) is celebrated worldwide on July 28, to emphasize the need for diagnosis for all patients and link them to care.
On Wednesday 8 July, the Private Assembly of Farmindustria appointed the new Presidential Committee for the two-year period 2020-2022.
Alfasigma has started a partnership with the European Society of Gastrointestinal Endoscopy (ESGE), being acknowledged as Premium Partner in all online activities throughout the year 2020.
Gastrointestinal therapeutics are our specialty. Everyday we strive to give a concrete answer to functional gastro-intestinal disorders, gastro-oesophageal reflux disorder, hepatic encephalopathy and chronic liver disease (cirrhosis).
Vascular investigation is a company corporate mission. Venous diseases, lower extremity artery disease, diabetic microangiopathies and ventricular arrhythmia are the main pathologies in which we offer solutions.
In the metabolic area, our R&D has developed Carnitine, an amino acid derivative whose insufficiency can impair the metabolism of essential tissues, such as those of the heart and muscles.
Nutraceuticals & Medical foods
With our supplements, we are responding to the demand for a vast range of elements aimed at neural tissue well-being, recovery of muscle tone and combating physical and mental fatigue.